VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 10/01/2021
** VAERS DATABASE Last updated: October 1, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.






Manufacturers

Total Manufacturer

Incidents per State

State Total
72,296
AK1,638
AL5,339
AR3,412
AS44
AZ13,316
CA58,147
CO11,002
CT7,824
DC1,626
DE1,670
FL36,235
FM3
GA13,429
GU82
HI2,195
IA4,332
ID2,473
IL19,261
IN22,568
KS4,284
KY6,945
LA4,714
MA13,886
MD11,901
ME2,997
MH8
MI17,865
MN11,345
MO8,919
MP30
MS2,676
MT2,147
NC15,401
ND1,273
NE2,732
NH2,859
NJ17,232
NM3,702
NV4,071
NY32,763
OH18,072
OK5,940
OR7,954
PA22,457
PR2,104
QM2
RI1,911
SC6,055
SD1,133
TN8,691
TX34,122
UT4,023
VA13,944
VI49
VT1,661
WA13,811
WI10,395
WV2,220
WY805
XB5
XL1
XV2

ID: 0973531
Sex: F
Age:
State: IL

Vax Date: 01/07/2021
Onset Date: 01/01/2020
Rec V Date: 01/26/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: little nauseous, queasy; low grade temperature; chills and shakes; scratchy throat; decreased sense of smell; decreased sense of taste; everything she eat or drinks has a metallic taste to it; muscle stiffness; Fatigue; arm soreness/right arm was still tender to touch/The first shot hurt way more and hurt all over the whole arm, it was throbbing; sinus pressure and congestion; sinus pressure and congestion; felt really lightheaded; low grade headache; chest feeling tight/chest tightness; she is not feeling good; wheeze; cough; This is a spontaneous report from a contactable nurse (patient). A 56-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via intramuscular (IM) in right deltoid on 07Jan2021 15:30 at second single dose for preventative. The patient medical history was not reported. There were no concomitant medications. The patient previously took H1N1 flut shot in 2015 or 2016 for immunisation and experienced muscle stiffness and fatigue, first dose bnt162b2, via IM in left deltoid for preventative on 18Dec2020 at 18:00 and patient was tender in her left arm, the first shot hurt way more and hurt all over the whole arm, it was throbbing. No additional vaccines administered on same date of the pfizer suspect. No prior other vaccinations administered within 4 weeks. The patient took the second dose of the Pfizer Covid vaccine on Thursday 07Jan2021 at 15:30. She called employee health and was advised to call Pfizer to report side effects since she is not feeling good. She had never had the covid diagnosis. On Friday (08Jan2021) she worked all day and felt arm soreness and sinus congestion but nothing out of the ordinary. The patient reported her right arm was still tender to touch, if she rotated her arm she can feel that she had the shot and she was still tender in her left arm from the first shot. The first shot hurt way more and hurt all over the whole arm, it was throbbing. On 08Jan2021 evening she felt really lightheaded, she thought maybe it was her sinuses since it is dry due to winter. She felt like a truck hit her. She had a low grade headache. On 09Jan2021, she felt a little nauseous, queasy, no vomiting. On Saturday (09Jan2021) she had a low grade temp of 100.3 degrees F. She had the chills and shakes on Saturday and most of yesterday. She got up today (reported on 12Jan2020) at 5:30 am, she checked her temperature and it was 97.2 after the shower, an hour later it was 98 degrees F. She felt like she had to keep clearing her throat, her chest felt a bit tight which started Friday evening, the chest tightness was not terrible but it was there. She was not wheezing but when she took a deep breath she felt a little like a wheeze and she had to cough, she had a scratchy throat on 09Jan2020. She stayed home from work yesterday. The patient did not feel lightheaded today, felt it yesterday and did not notice it at all this morning, reported it has resolved. The sinus pressure and congestion started Friday night, she felt stuffy. She had a decreased sense of smell and taste on 09Jan2021. Unless something is right in front of her, she could not smell anything. She felt quite nauseous this morning but at the moment her nausea is under control. She had a decreased sense of taste, everything she ate or drunk had a metallic taste to it, on 09Jan2021. She felt that all the side effects mentioned were related to getting the vaccine. On 08Jan2021, she also experienced muscle stiffness and fatigue which had improved after a hot shower, that helped. She felt like she had a bad flu shot. The only time she ever felt similar to this was when she received the H1N1 flut shot in 2015 or 2016. She did not have lot number, NDC, or expiration date to provide. Treatment included: took Tylenol on Saturday. The events did not require a visit to emergency room and physician office (she is trying to get an appointment to see the doctor). Outcome of the event lightheaded was recovered on 12Jan2021, of events low grade headache, chest tightness, scratchy throat, sinus pressure and congestion, decreased sense of smell, decreased sense of taste, everything she eat or drinks has a metallic taste to it, arm soreness was not recovered, of events chills and shakes, muscle stiffness, fatigue was recovering, of other events was unknown. Information about Lot/Batch has been requested.

Other Meds:

Current Illness:

ID: 0973532
Sex: F
Age:
State: CA

Vax Date: 01/07/2021
Onset Date: 01/07/2021
Rec V Date: 01/26/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: slight fever; Headache; chills; aches; joint pain; This is a spontaneous report from a contactable nurse (patient). A 63-year-old female patient received her second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number-EL3246), via an unspecified route of administration on left arm at 10:30 AM on 07Jan2021 at single dose for COVID-19 immunization. Medical history included thyroid disorder and known allergies: PCN (Penicillin). Concomitant medication included levothyroxine sodium (SYNTHROID), curcumin and vitamins. The patient previously received her first dose of BNT162B2 (lot number=EH9899) on left arm at 10:45 AM on 17Dec2020 for COVID-19 immunization. The patient experienced headache, chills, aches and joint pain with slight fever on 07Jan2021 at 22:00. Prior to vaccination, the patient was not diagnosed with COVID-19; Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any treatment for events. The outcome of events was recovered in Jan2021.

Other Meds: SYNTHROID; CURCUMIN

Current Illness:

ID: 0973533
Sex: M
Age:
State: NY

Vax Date: 01/09/2021
Onset Date: 01/11/2021
Rec V Date: 01/26/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: eyebrows swollen; area of his eyebrows is swollen and resting right on his eyelids; lymph nodes swollen; This is a spontaneous report from a contactable consumer reported for himself. A 29-year-old male patient received bnt162b2 (BNT162B2, PFIZER-BIONTECH COVID-19 VACCINE, lot number: EK5730 and expiration date: 31Mar2021), via an unspecified route of administration on arm left on 09Jan2021 11:45 at 0.3mL, single for covid-19 immunisation. The patient medical history reported as none. There were no concomitant medications. The patient previously took Influenza Quadrivalent (lot number: 294G5 and expiry date: 30Jun2021) at the age of 29-year-old on 20Oct2020 at 0.5mL and never had any problems. The patient having a side effect from the dose he got on Saturday 09Jan2021. He woke up yesterday on 11Jan2021, with his eyebrows swollen, the area of his eyebrows is swollen and resting right on his eyelids. Also reported woke up yesterday on 11Jan2021 with the swollen eyelids and swollen lymph nodes, are a little swollen but have seemed to subside as of today. The outcome of the events swollen eyelid and swollen lymph nodes was recovering, outcome of the other event was not recovered.

Other Meds:

Current Illness:

ID: 0973534
Sex: F
Age:
State:

Vax Date: 01/12/2021
Onset Date: 01/12/2021
Rec V Date: 01/26/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: felt liquid come out of the injection site; felt liquid come out of the injection site; felt liquid come out of the injection site; did not feel like she got the right amount of vaccine; This is a spontaneous report from a contactable pharmacist (patient). An adult (reported as "30-40") female patient received the second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot/batch number and expiration date not provided), via an unspecified route of administration on 12Jan2021 13:27 at single dose in left deltoid for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient previously received the first dose of bnt162b2 on 22Dec2020 in left deltoid for COVID-19 immunization and experienced arm was a little sore. The patient had her 2nd vaccine dose today at 1:27pmET. After she received the dose she felt liquid come out of the injection site. The patient did not feel like she got the right amount of vaccine. The reporter wanted to know if there was any information about measuring titers, or if there was any data on getting a third dose, any information about not being immune and asked if the second dose was not administered properly. The outcome of the events was unknown. Information on lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 0973535
Sex: F
Age:
State: NC

Vax Date: 01/11/2021
Onset Date: 01/11/2021
Rec V Date: 01/26/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: increased appetite; Hot flashes; itching; This is a spontaneous report from a contactable consumer (patient). A 31-year-old female patient (non-pregnant) received 1st dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot: El3302), via an unspecified route of administration on 11Jan2021 18:45 at single dose on left arm for COVID-19 immunisation. The patient medical history was not reported. There were no concomitant medications. The patient experienced increased appetite, hot flashes and itching, all on 11Jan2021 20:00 with outcome of not recovered. No treatment was received for the events. No COVID prior vaccination. No COVID tested post vaccination. No COVID tested post vaccination.

Other Meds:

Current Illness:

ID: 0973536
Sex: M
Age:
State: KS

Vax Date: 01/11/2021
Onset Date: 01/11/2021
Rec V Date: 01/26/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: experience allergy symptoms; scratchy throat which is chronic; This is a spontaneous report from contactable pharmacist. A 32-year-old male patient received the second of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EK9231), intramuscular on 11Jan2021 at single dose in left deltoid for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient previously took the first dose of bnt162b2 for COVID-19 immunization. Facility type vaccine was Workplace clinic. It was unknown if other vaccine in four weeks. The patient was seen at SVH COVID Vaccine Clinic today for his second dose of the COVID 19 vaccination. He denied any history of previous adverse reactions to vaccines. He was given the Pfizer vaccination in the left deltoid muscle. On 11Jan2021, during his 30 minutes waiting period after the injection, the patient began to experience allergy symptoms scratchy throat which was chronic. He denied rash, hives, welts, difficulty breathing, difficulty swallowing, wheezing, throat tightness, hoarseness, stridor, itching, lightheadedness, dizziness, facial swelling, lip swelling and tongue swelling. This provider was notified of patient reaction and he was then assessed in the emergency bay area. Monitored patient for severe reaction symptoms, including but not limited to scratchy throat. No treatment received for the adverse events. The outcome of the events was recovered in Jan2021.

Other Meds:

Current Illness:

ID: 0973537
Sex: F
Age:
State: AL

Vax Date: 01/11/2021
Onset Date: 01/12/2021
Rec V Date: 01/26/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: muscle pain all over my body; chills; feel the lump in the same area/left armpit; This is a spontaneous report from a contactable consumer. A 34-years-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number and expiry date not reported), via an unspecified route of administration on 11Jan2021 13:00 (1PM) at a single dose in the left arm for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient was not pregnant at the time of the vaccination. The patient had no Covid prior to vaccination. The patient had no other vaccine in four weeks and no other medications in two weeks. The patient previously took acetylsalicylic acid (ASPIRIN) and experienced allergies. The patient had first dose of bnt162b2 for covid-19 immunization on 21Dec2020, 03:30 PM, in the left arm (number and expiry date not reported) and after the administration of the vaccine, patient discovered a lump on the bottom of the left armpit; felt a lot of discomfort when touching it and it went away around 02Jan2021. Post vaccination, patient was tested for Covid as nasal swab on 07Jan2021 with result as negative. When the second vaccine was administered, patient felt muscle pain all over her body, chills and started to feel the lump in the same area (left armpit) the day after the vaccine was administered (12Jan2021). No treatments received in response to the events reported. The patient did not recover from the events muscle pain all over her body, chills, and lump in the same area (left armpit). Information on Lot/Batch number has been requested.

Other Meds:

Current Illness:

ID: 0973538
Sex: F
Age:
State: NY

Vax Date: 01/11/2021
Onset Date: 01/12/2021
Rec V Date: 01/26/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Sudden abdominal pain 12 hours after vaccination and vomiting.; Sudden abdominal pain 12 hours after vaccination and vomiting; This is a spontaneous report from a non-contactable consumer(patient). A 26-year-old female patient received first dose BNT162B2, via an unspecified route of administration at left arm on 11Jan2021 14:30 at single dose for COVID-19 immunization . Patient had other medications in two weeks. There was no other vaccine in four weeks. The patient medical history was not reported. There was no covid prior vaccination, no covid tested post vaccination, no Known allergies. The patient experienced sudden abdominal pain 12 hours after vaccination and vomiting on 12Jan2021 03:00 with outcome of recovering. There was no treatment received. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 0973539
Sex: U
Age:
State: TN

Vax Date: 01/11/2021
Onset Date: 01/01/2021
Rec V Date: 01/26/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: welts and rashes; welts and rashes; This is a spontaneous report from a contactable nurse. This nurse reported similar events for two patients. This is the 1st of the two reports. A patient of unspecified age and gender received the second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiration date: unknown), via an unspecified route of administration on 11Jan2021 at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient previously received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) on an unspecified date for COVID-19 immunization. The nurse reported that the patient received the second dose of the vaccine on Monday (11Jan2021) and broke out in welts and rashes in Jan2021. The patient went to the ER and was given steroid treatments. The patient did not report respiratory distress. The outcome of the events was unknown Information on the batch/lot number has been requested.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021026638 Same reporter/drug; different patient/event.

Other Meds:

Current Illness:

ID: 0973540
Sex: F
Age:
State: ME

Vax Date: 01/10/2021
Onset Date: 01/11/2021
Rec V Date: 01/26/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Injection site red; Tennis ball sized hard lump; Injection site pain; Injection site Swollen; Facial pain; Fatigue; Headache; This is a spontaneous report from a contactable other Health Professional (patient). A 34-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot# EL1284), intramuscularly in left arm on 10Jan2021 08:00 at single dose for COVID-19 immunization. The patient medical history was not reported. Known allergies: No. Other medical history: No. The patient was not pregnant. The patient's concomitant medications were not reported. If other vaccine in four weeks: No. Other medications in two weeks: No. Facility type vaccine: Hospital. The patient previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot# EH9899) on 20Dec2020 for COVID-19 immunization. The patient experienced injection site pain, swollen, red, tennis ball sized hard lump, fatigue, headache, facial pain, all on 11Jan2021 06:00 with outcome of recovering. No treatment received for all the events. If COVID prior vaccination: No. If COVID tested post vaccination: No.

Other Meds:

Current Illness:

ID: 0973541
Sex: U
Age:
State:

Vax Date:
Onset Date: 01/05/2021
Rec V Date: 01/26/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: the patient got a positve COVID-19 test result; the patient got a positve COVID-19 test result; This is a spontaneous report from a contactable other healthcare professional (hcp). This hcp reported the same events for 2 patients. This is the second of two reports. A patient of unspecified age and gender received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot/batch number and expiration date were unknown), via an unspecified route of administration on an unspecified date at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient got a positve COVID-19 test result on 05Jan2021. Outcome of the events was unknown. Information on the lot/batch number has been requested.; Sender's Comments: The efficacy of a drug varies from patient to patient and can be affected by different factors; however, a contributory role of the suspect product BNT162B2 to the reported drug ineffective and COVID-19 cannot be ruled out.,Linked Report(s) : US-PFIZER INC-2021020999 same drug/events/reporter, different patients

Other Meds:

Current Illness:

ID: 0973542
Sex: F
Age:
State:

Vax Date: 12/22/2020
Onset Date: 12/22/2020
Rec V Date: 01/26/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Very swollen and erythematous arm; Very swollen and erythematous arm; chills; severe neck pain; myalgias; This is a spontaneous report from a contactable nurse reported for herself. A 60-year-old female patient (not pregnant) received first dose of bnt162b2 (Lot number: Ek5730), via an unspecified route of administration in left arm on 22Dec2020 11:30 at single dose for COVID-19 immunization. Medical history included covid-19 from an unknown date and unknown if ongoing (COVID prior vaccination: Yes). There were no concomitant medications. The patient experienced very swollen and erythematous arm, chills, severe neck pain, myalgias, all on 22Dec2020 14:00. The adverse event was not resulted in a visit to doctor or other healthcare professional office/clinic or Emergency room/department or urgent care. No treatment given. The outcome of events was resolved. Facility type vaccine: Hospital. No other vaccine in four weeks. No other medications in two weeks. No COVID tested post vaccination. Not known allergies or other medical history.

Other Meds:

Current Illness:

ID: 0973543
Sex: F
Age:
State: NY

Vax Date: 12/19/2020
Onset Date: 01/07/2021
Rec V Date: 01/26/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: 103 degree Fahrenheit fever; chills; nausea; fatigue; headache; This is a spontaneous report from a contactable nurse (patient). This 31-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 19Dec2020 08:15 at single dose at left arm for COVID-19 immunization. The patient's medical history included hypertension. No known allergies. The patient's concomitant medications included ergocalciferol (VIT D), ascorbic acid (VIT C) and Beta blocker. No other vaccine received in four weeks. Patient was not pregnant. Facility type vaccine was hospital. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient hasn't been tested for COVID-19. Patient received second dose on 07Jan2021 19:45 at left arm for COVID-19 immunization. The patient experienced 103 degree Fahrenheit fever, chills, nausea, fatigue, headache for 48 hours on 07Jan2021 19:30. No treatment received. Outcome of the events was recovered. Information about Lot/Batch has been requested.

Other Meds: VIT D; VIT C

Current Illness:

ID: 0973544
Sex: F
Age:
State:

Vax Date: 01/11/2021
Onset Date: 01/11/2021
Rec V Date: 01/26/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Fever; chills; headache; Injection site pain; This is a spontaneous report from a non-contactable physician (patient). A 29-year-old female patient received her second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number= EL3248), intramuscularly on right arm at 09:45 on 11Jan2021 at single dose for COVID-19 immunization. Medical history reported as none. There were no concomitant medications. The patient previously received her first dose of BNT162B2 (Lot number= EL1284) intramuscularly on left arm on 22Dec2020 at 20:30 for COVID-19 immunization. The patient experienced injection site pain 6 hours after second dose, fever, chills, headache that started 14 hours after the second dose on 11Jan2021. Prior to vaccination, the patient was not diagnosed with COVID-19; Since the vaccination, the patient had been tested for COVID-19. Therapeutic measures were taken as a result of events. The outcome of events was recovering. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 0973545
Sex: F
Age:
State:

Vax Date: 01/11/2021
Onset Date: 01/11/2021
Rec V Date: 01/26/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Headache; fever; chills; joint pain; muscle pain; fatigues; This is spontaneous report from a contactable other HCP. A 36-year-old female patient started to receive BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 11Jan2021 09:45 at single dose for covid-19 immunization. Vaccine location was left arm and it was the second dose. Patient took the first dose on 23Dec2020 at arm left for covid-19 immunization. Medical history included asthma from an unknown date. Allergies to medications included Lamictal and Penicillin. There were no concomitant medications. The facility type vaccine was hospital. Patient was not diagnosed with COVID-19 prior to vaccination nor tested for COVID-19 since the vaccination. The patient didn't receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient experienced headache, fever, chills, joint pain, muscle pain, and fatigue on 11Jan2021 with outcome of not recovered. Patient didn't receive treatment for the adverse events. The events were reported as non-serious. Information on the batch number and lot number has been requested.

Other Meds:

Current Illness:

ID: 0973546
Sex: F
Age:
State: NY

Vax Date: 01/11/2021
Onset Date: 01/11/2021
Rec V Date: 01/26/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: chills; severe all over body aches especially left arm; headache; sleeplessness; This is a spontaneous report from a contactable other HCP (patient). A 50-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: el0142) intramuscularly at left arm on 11Jan2021 16:15 at single dose for COVID-19 immunization. Medical history included herniated disk L5 S1. No known allergies. Concomitant medication included escitalopram oxalate (LEXAPRO), ergocalciferol (VITAMIN D), ascorbic acid (VITAMIN C), vitamin b complex (VITAMIN B), cefixime (FLEXERIL), calcium, magnesium, curcuma longa (TURMERIC). The patient previously received first dose of bnt162b2 (lot number: ek5730) intramuscularly at left arm on 21Dec2020 15:45 at single dose for COVID-19 immunization. The patient experienced chills, severe all over body aches especially left arm, headache, sleeplessness, on 11Jan2021 23:30. No treatment received. No other vaccine in four weeks. No COVID prior vaccination. No COVID tested post vaccination. The outcome of the events was recovering.

Other Meds: Lexapro; Vitamin D [Ergocalciferol]; Vitamin C [Ascorbic Acid]; Vitamin B; Flexeril [Cefixime]; Calcium; Magnesium; Turmeric [Curcuma Longa]

Current Illness:

ID: 0973547
Sex: M
Age:
State: CA

Vax Date: 12/23/2020
Onset Date: 12/23/2020
Rec V Date: 01/26/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: fatigue; headache; body aches; dizziness; This is a spontaneous report from a contactable healthcare professional (patient). A 28-year-old male patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EK5730, expiry date not reported), intramuscular in the left arm on 23Dec2020 08:00 at single dose for COVID-19 immunisation. Medical history was not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with COVID-19 prior to vaccination. Since the vaccination, the patient has not been tested for COVID-19. The patient had no allergies to medications, food, or other products. Concomitant medications included caffeine, paracetamol (EXCEDRIN), and paracetamol (TYLENOL). On 23Dec2020, the patient experienced fatigue, headache, body aches and dizziness. No treatment was received for the adverse events. Clinical outcome of the events was recovering.

Other Meds: Excedrin; Tylenol

Current Illness:

ID: 0973548
Sex: F
Age:
State: TN

Vax Date: 01/01/2021
Onset Date: 01/11/2021
Rec V Date: 01/26/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: supraclavicular lymph node swelled to about pea size after 1st dose and stayed that size until 2nd dose. Swelled to size of moth ball after 2nd dose; supraclavicular lymph node swelled to about pea size after 1st dose and stayed that size until 2nd dose. Swelled to size of moth ball after 2nd dose; day after 2nd dose all joints felt stiff and extremely sore; day after 2nd dose all joints felt stiff and extremely sore; Incredibly lethargic with headache and brain fog; Incredibly lethargic with headache and brain fog; This is a spontaneous report from a contactable other HCP. This other HCP (Patient) reported for self that the 49-year-old female patient who received second dose of bnt162b2 (BNT162B2), via an unspecified route of administration on Jan2021 06:00 AM on Left arm at single dose for covid-19 immunisation. She is not pregnant. Medical history included known allergies: Augmentin. The patient previously took first dose of bnt162b2 via an unspecified route of administration on Dec2020 06:00 AM on Left arm at single dose for covid-19 immunisation and experienced Supraclavicular lymph node swelled to about pea size after 1st dose. Concomitant medications included in two weeks Sertraline 50 mg, Vitamin D3 5000 IU. Facility type vaccine was Hospital. No other vaccine in four weeks. The patient experienced supraclavicular lymph node swelled to about pea size after 1st dose and stayed that size until 2nd dose. Swelled to size of moth ball after 2nd dose. day after 2nd dose all joints felt stiff and extremely sore. Incredibly lethargic with headache and brain fog. The events started from 11Jan2021 04:00 PM. The outcome of the events was recovered with lasting effects. No treatment was received. No COVID prior vaccination. No COVID tested post vaccination. Information about lot/batch number has been requested.

Other Meds: Sertraline; Vitamin D3

Current Illness:

ID: 0973549
Sex: F
Age:
State: VA

Vax Date: 12/19/2020
Onset Date:
Rec V Date: 01/26/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Moderate soreness at injection site; This is a spontaneous report from a contactable other hcp (patient). A 36-year-old non-pregnant female received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number= EK 5730), via an unspecified route of administration on 19Dec2020 08:15 at 35 years old at left arm at single dose for covid-19 immunization. Facility type vaccine was doctor's office/urgent care. NO other vaccine in four weeks. Medical history included migraine. No known allergies. Concomitant medication included sumatriptan succinate (IMITREX) 100 mg PRN (As needed) for migraines, ethinylestradiol, norgestimate (SPRINTEC) 28 day. The patient experienced moderate soreness at injection site only for 2 days on an unspecified date. No Covid prior vaccination and covid was not tested post vaccination. The outcome of the event was recovered.

Other Meds: Imitrex; Sprintec

Current Illness:

ID: 0973550
Sex: M
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 01/26/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: muscle pain in the arm where patient got the Pfizer shot; weakness; This is a spontaneous report from a contactable other healthcare professional (patient). A male patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date at single dose at arm for covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient experienced muscle pain in the arm where patient got the Pfizer shot, and weakness that faded after a day on an unspecified date. Outcome of event muscle pain in the arm was unknown, and outcome of event weakness was recovered. No follow-up attempts are possible. Information about Lot/Batch can not be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 0973551
Sex: M
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 01/26/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: felt muscle pain in the arm where they got the Pfizer shot; headache; This is a spontaneous report from a contactable nurse. A male patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date at single dose for COVID-19 immunization. The patient medical history was not reported. The patient's concomitant medications were not reported. The patient experienced felt muscle pain in the arm where they got the Pfizer shot and headache on an unspecified date. Therapeutic measures were taken as a result of headache included pain killer. Outcome of headache was recovered, other was unknown. No follow-up attempts are possible. Information about Lot/Batch cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 0973552
Sex: F
Age:
State: VA

Vax Date: 01/09/2021
Onset Date: 01/09/2021
Rec V Date: 01/26/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: warm to touch; Small red, raised, palpable lump warm to touch about the size of the dime by 6pm on same day as injection; Severe burning with injection followed by mild soreness at arm; Severe burning with injection followed by mild soreness at arm; redness; moderate soreness; Itchy; This is a spontaneous report from a contactable Other HCP (patient). This 36-year-old female (not pregnant) patient received 2nd dose of BNT162B2 (Covid vaccine, lot number=EK4176 on 09Jan2021 09:30 AM on Left arm for covid-19 immunization. Medical history was migraines. Concomitant drug was sumatriptan succinate (IMITREX) for migraines, ethinylestradiol norgestimate (SPRINTEC). Historical Vaccine was 1st dose of BNT162B2 on 19Dec2020 08:15 AM (lot number=EK 5730, vaccine location=Left arm) and experienced moderate soreness at injection site only x2 days. It was reported that patient experienced Severe burning with injection followed by mild soreness at arm. Small red, raised, palpable lump warm to touch about the size of the dime by 6pm on same day as injection. 10Jan2021 - moderate soreness. Area remains bright red, raised, warm to touch increased in size to 1"x1" 24 hours after vaccine. 11Jan2021 - 48 hours post vaccine area further enlarged to 2"x2". Moderate soreness. Itchy. Warm to touch. Palpable area extending to edge of redness. 12Jan2021 - 72 hours. No soreness except when touching injection site. Redness less in color and size. No longer itchy. Palpable lump smaller. Quarter size. Treatment was Tylenol. Outcome of the event palpable lump, Redness was recovering, for itchy was recovered, for other events was Not recovered. No covid prior vaccination. No covid tested post vaccination. No follow-up attempts are needed. No further information is expected.

Other Meds: Imitrex; Sprintec

Current Illness:

ID: 0973553
Sex: F
Age:
State: MI

Vax Date: 01/12/2021
Onset Date: 01/12/2021
Rec V Date: 01/26/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Minor itching of arms (not at injection site) and around lips.; Minor itching of arms (not at injection site) and around lips.; This is a spontaneous report from a contactable consumer. A 35-year-old female patient started to receive bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL1283, expiration date not reported), via an unspecified route of administration at the right arm on 12Jan2021 14:45 at single dose for COVID-19 immunization. Medical history included Latex allergy, chronic migraine, seasonal allergies, and had previous anaphylaxis due to insect stings. Concomitant medication included sumatriptan. The patient previously took Tylenol and experienced allergy. It was reported that the patient experienced minor itching of arms (not at injection site) and around lip. It was reported that the event started shortly after the thirty minute (15:15) wait after injection and ended around an hour after injection (15:45). Patient further reported that she has previous history of anaphylaxis due to insect stings. It was not bad enough to seek treatment and it took a bit to realize that it wasn't just a result of her worrying, but it was noticeable. No hives, no redness. Patient did not feel the need to seek treatment, but she did monitor symptoms until they eased. Vaccine was from a vial with no latex, due to existing minor allergy. No treatment was given to the patient in response to the event. There was no COVID prior to vaccination and no COVID test post vaccination. The patient recovered from the event on 12Jan2021 at 13:45.

Other Meds: Sumatriptan

Current Illness:

ID: 0973554
Sex: F
Age:
State: WI

Vax Date: 01/06/2021
Onset Date: 01/10/2021
Rec V Date: 01/26/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: day 5 of the second shot I woke up extremely hot, felt like my skin And everything around me was burning/overheating; I also had mild hot flashes after the second vaccine and headaches; I also had mild hot flashes after the second vaccine and headaches; This is a spontaneous report from a contactable nurse (patient). A 35-year-old female patient (pregnant: No) received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: Ej1685) intramuscular at left arm on 06Jan2021 10:30 at single dose for COVID-19 immunization. Medical history included Asthma, hypothyroidism, ADD. Concomitant medications were not reported. Patient had known allergies to erythromycin and seasonal allergies. it was unknown if covid prior vaccination. There were other medications in two weeks. Patient used took first dose of BNT162B2 (lot number: Ej1685) on 17Dec2020 at left arm at single dose for COVID-19 immunization and experienced extreme episode of overheating (at night) the first time, got up and almost passed out. It was reported day 5 after both shots patient had an extreme episode of overheating (at night) the first time she got up and almost passed out. day 5 of the second shot she woke up extremely hot, felt like her skin and everything around her was burning, it was inescapable, she had to open a window and wait it out, lasted about 30 minutes. she also had mild hot flashes after the second vaccine and headaches. adverse event start date was 10Jan2021. No covid tested post vaccination. no treatment received for the events. Patient was recovering from the events.

Other Meds:

Current Illness:

ID: 0973555
Sex: M
Age:
State: IL

Vax Date: 01/08/2021
Onset Date: 01/03/2021
Rec V Date: 01/26/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Runny nose; tachycardia; Weakness; flu like symptoms; Sore/dry throat; Sore/dry throat; nausea; This is a spontaneous report from a contactable nurse (patient). A 26-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), intramuscularly on the left arm, first dose on 18Dec2020 (lot number: EH9899) and second dose on 08Jan2021 08:15 (lot number: EL3246), both at a single dose for COVID-19 immunization. Medical history included COVID prior vaccination. Concomitant medications were not reported. Patient did not receive other vaccines in four weeks prior to vaccination. The vaccine was given at a hospital. The patient reported sore/dry throat and nausea started Sunday (03Jan2021), weakness and flu-like symptoms on Monday (04Jan2021), then runny nose and tachycardia on Tuesday (05Jan2021). No treatment was received for the events. Patient has not been tested for COVID post-vaccination. Outcome of the events was not recovered.

Other Meds:

Current Illness:

ID: 0973556
Sex: F
Age:
State: TX

Vax Date: 01/08/2021
Onset Date: 01/08/2021
Rec V Date: 01/26/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: numbness of left side of face/scalp; hyperesthesia of left face/scalp/ear; left sided submandibular lymphadenopathy; This is a spontaneous report from a contactable physician. A 37-years-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number and expiry date not reported), intramuscular on 08Jan2021 10:45 at a single dose for COVID-19 immunization. Medical history included rheumatoid arthritis from an unknown date and unknown if ongoing.The patient had no known allergies. It was unknown if patient had COVID prior to vaccination. The patient was not pregnant at the time of the vaccination. The patient's concomitant medications were not reported. The patient had no other vaccine in four weeks. The patient had the first dose of bnt162b2 for covid-19 immunization on 18Dec2020 (lot number unknown), via intramuscular route in the left arm. The vaccination was administered in the hospital. On 08Jan2021, the patient experienced numbness of left side of face/scalp, hyperesthesia of left face/scalp/ear, and left sided submandibular lymphadenopathy. The events resulted in a doctor or other healthcare professional office/clinic visit. The patient received treatment as gabapentin for the reported events. The patient was not tested for covid post vaccination. The events numbness of left side of face/scalp, hyperesthesia of left face/scalp/ear, and left sided submandibular lymphadenopathy were not recovered. Information on lot number/batch number was requested.

Other Meds:

Current Illness:

ID: 0973557
Sex: F
Age:
State:

Vax Date: 01/11/2021
Onset Date:
Rec V Date: 01/26/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Chills; Fever; This is a spontaneous report from a contactable consumer. A female patient of unspecified age received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiration date unknown), via an unspecified route of administration on 11Jan2021 at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient received the first dose of the vaccine the day before and is having chills and fever on unknown date, and she would like to know what they can take for that since they had none of this information from the place where she got the vaccine at, no information on what to take for a reaction. The outcome of the events was unknown. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 0973558
Sex: M
Age:
State: WA

Vax Date: 12/22/2020
Onset Date: 12/23/2020
Rec V Date: 01/26/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: had cramping, pinching pain in his left superior trapezius/supraspinatus thinking brachial plexus involvement; had cramping, pinching pain in his left superior trapezius/supraspinatus thinking brachial plexus involvement; This is a spontaneous report from a contactable other health professional (patient). A 65-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number EL0149), via an unspecified route of administration in arm left on 22Dec2020 09:45 at single dose for COVID-19 immunization. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient did not have COVID tested post vaccination and did not have COVID prior vaccination. Medical history included known allergies: Sulpha, PCN. Concomitant medication included famotidine (PEPCID). The patient had cramping, pinching pain in his left superior trapezius/supraspinatus thinking brachial plexus involvement on 23Dec2020. The patient did not received treatment. Duration 10 days. Resolved without intervention. The outcome of events was recovered on 02Jan2021.

Other Meds: Pepcid (Famotidine)

Current Illness:

ID: 0973559
Sex: M
Age:
State: NJ

Vax Date: 01/09/2021
Onset Date: 01/10/2021
Rec V Date: 01/26/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: fever to 38.3; This is a spontaneous report from a contactable physician. A 69-year-old male patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EK9231) intramuscular on left arm single dose for COVID-19 immunization on 09Jan2021, 06:30 PM, at 69-year-old. Medical history included: hypertension. No known allergies. The patient did not have COVID prior vaccination. Concomitant medications in two weeks included: amlodipine, benazepril. The patient did not have other vaccine in four weeks. The patient previously took the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) intramuscular on left arm for COVID-19 immunization on 19Dec2020, 06:30 PM, at 69-year-old. On 10Jan2021, 07:00 PM, the patient had fever to 38.3 which lasted about two hours. Treatment received as: acetaminophen 500 mg. The patient was not tested for COVID post vaccination. Action taken for BNT162B2 was not applicable. Outcome of the event was resolved on 10Jan2021, 09:00 PM.

Other Meds: Amlodipine; Benazepril

Current Illness:

ID: 0973560
Sex: M
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 01/26/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Sore arm; This is a spontaneous report from a contactable consumer (patient). A male patient of an unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), via an unspecified route of administration on an unspecified date at single dose for covid-19 immunization. The patient medical history and concomitant medications were not reported. With the first one, the patient didn't feel any side effects other than a sore arm. The outcome of event was unknown. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 0973561
Sex: M
Age:
State: NV

Vax Date: 12/22/2020
Onset Date: 01/06/2021
Rec V Date: 01/26/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: He tested positive for Covid- 3 days without symptoms; He tested positive for Covid- 3 days without symptoms; This is a spontaneous report from a Pfizer-sponsored program Pfizer First Connect, by a contactable consumer (patient). This male patient of an unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration at single dose on 22Dec2020 for Covid-19 immunisation. The patient medical history and concomitant medications were not reported. On 06Jan2021, the patient tested positive for Covid, 3 days without symptoms with outcome of unknown. He asked if it's okay to get the second dose. The patient underwent lab tests and procedures which included Sars CoV-2 test: positive on 06Jan2021. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 0973562
Sex: F
Age:
State: CA

Vax Date:
Onset Date: 01/01/2021
Rec V Date: 01/26/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: tested positive; tested positive; This is a spontaneous report from a Pfizer Sponsored Program Pfizer First Connect via a contactable female nurse reported for herself. The female patient of an unspecified age received first dose BNT162B2(Covid-19) , via an unspecified route of administration on an unspecified date at single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. The patient tested positive after she got the 1st vaccine, and got sick, both in Jan2021. Outcome of events was unknown. Information about Lot/Batch has been requested.; Sender's Comments: A causal association between BNT162B2 and the reported events cannot be excluded based on a compatible temporal relation. However, full immunity is only expected 2 weeks after the second dose.

Other Meds:

Current Illness:

ID: 0973563
Sex: F
Age:
State: OK

Vax Date: 01/12/2021
Onset Date: 01/13/2021
Rec V Date: 01/26/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: fatigue; headache; muscle ache; injection pain site; This is a spontaneous report from a contactable consumer (patient). A 54-year-old non-pregnant female patient received her first dose of bnt162b2 (BNT162B2 reported as PFIZER COVID 19 VACCINE; lot number: El1283; expiration date: unknown), via an unspecified route of administration right arm on 12Jan2021 17:15 at SINGLE DOSE for covid-19 immunization. Medical history included diabetic, high blood pressure, high cholesterol, ADHD (attention deficit hyperactivity disorder), anxiety, depression and IBS (irritable bowel syndrome). The patient has no allergies to medications, food, or other products. The patient was not diagnosed with COVID-19 prior to vaccination. Concomitant medication included lovastatin (LOVASTAT), bupropion hydrochloride (BUPROPION HCL XL) and networking 750mg. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient received the Pfizer Covid 19 vaccine in a hospital. The patient experienced fatigue, headache and muscle ache and injection pain site on 13Jan2021 06:00 PM (18:00). The patient did not received treatment for the adverse events. The events were reported as non-serious. The patient has not been tested for COVID-19 since vaccination. The outcome of the events was recovering.

Other Meds: Lovastatin; Bupropion HCL XL

Current Illness:

ID: 0973564
Sex: F
Age:
State: SC

Vax Date: 01/09/2021
Onset Date: 01/09/2021
Rec V Date: 01/26/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Headache; nausea; congestion; muscle aches; extreme joint pain; fatigue; dizziness; neck pain; fever; chills; tachycardia; This is a spontaneous report from a contactable other health professional reporting for herself. A 34-year-old female patient received the second dose of bnt162b2 (BNT162B2, lot number: EL3246, expiry date: not reported), intramuscular, on 09Jan2021 10:30 AM, at a single dose on the left arm for COVID-19 immunization. The most recent COVID-19 vaccine was administered at a hospital. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not pregnant at time of vaccination. The patient was not diagnosed with COVID-19 prior to vaccination. Medical history included gastrooesophageal reflux disease (GERD). She had no allergies to medications, food, or other products. Concomitant medications included esomeprazole sodium (NEXIUM). The patient previously received the first dose of bnt162b2 (BNT162B2, lot number: EJ1685, expiry date: not reported), intramuscular, on 19Dec2020 12:00 PM, at a single dose on right arm for COVID-19 immunization. On 09Jan2021 11:00 AM, the patient experienced headache, nausea, congestion, muscle aches, extreme joint pain, fatigue, dizziness, neck pain, fever, chills and tachycardia. The adverse events resulted to Doctor or other healthcare professional office/clinic visit. Since the vaccination, the patient has been tested for COVID-19; she had undergone Nasal Swab, test name: COVID-19 nasopharyngeal swab, on 11Jan2021 with result of negative. The patient received metoprolol as corrective treatment for the reported adverse events. Outcome of the events was recovering.

Other Meds: Nexium [Esomeprazole Sodium]

Current Illness:

ID: 0973565
Sex: F
Age:
State:

Vax Date: 01/06/2021
Onset Date: 01/01/2021
Rec V Date: 01/26/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: having a quite few side effects/not feeling well; This is a spontaneous report from a Pfizer-sponsored program via a contactable female consumer(patient). The female patient of an unspecified age received second dose BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) , via an unspecified route of administration on 06Jan2021 at single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. She previously received first dose BNT162B2 for COVID-19 immunization. The patient got the 2nd dose of vaccine last week 06Jan2021 but she's still having a quite few side effects/not feeling well in Jan2021. Outcome of event was not recovered. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 0973566
Sex: U
Age:
State: IL

Vax Date:
Onset Date:
Rec V Date: 01/26/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: flu like symptoms; This is a spontaneous report from a contactable physician (patient). An unknown age and gender patient received 1st and 2nd dose of BNT162B2 (COVID 19 vaccine) at single dose for covid-19 immunization. Medical history and concomitant drug were not reported. Patient experienced flu like symptoms after 2nd dose of the Covid 19 vaccine. Subsided the following day. Was able to go for a run. Symptoms were more severe after 2nd dose than first. Event took place after use of product. Outcome of the event was unknown. No follow-up attempts are possible. Information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 0973567
Sex: F
Age:
State: IL

Vax Date: 01/13/2021
Onset Date: 01/13/2021
Rec V Date: 01/26/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: metallic taste in mouth (went away with sleep and gone with wake up)/metallic taste in mouth came back; Muscle tension in left neck area and left upper back; This is a spontaneous report from a contactable other health professional (reporting for herself). A 35-year-old female patient received, BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), LOT number: EL 3247 via an unspecified route of administration, on 13Jan2021 15:15 at a single dose, for covid-19 immunization. The patient's medical history was not reported. Concomitant medication included sertraline. On 13Jan2021 15:20 The patient experienced muscle tension in left neck area and left upper back. On the 1st day after vaccination (14Jan2021 21:15), patient experienced metallic taste in mouth which went away with sleep and gone with wake up but on 2nd day after vaccination 15Jan2021 at 7:30, metallic taste in mouth came back. The outcome of events was not recovered. Patient did not received treatment due to the events. Events were considered non-serious. No follow-up attempts are possible. No further information is expected. Information on the lot/batch number has been obtained.

Other Meds: Sertraline

Current Illness:

ID: 0973568
Sex: F
Age:
State: CA

Vax Date: 01/06/2021
Onset Date: 01/14/2021
Rec V Date: 01/26/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Foul taste. Everything tastes like it was slathered in old butter. Nothing tastes right; This is a spontaneous report from a contactable nurse reporting for herself. A 58-year-old female patient received the second dose of bnt162b2 (BNT162B2, lot number: EL3246, expiry date: not reported), via an unspecified route of administration, on 06Jan2021 04:30 PM at a single dose on the left arm for COVID-19 immunization. The most recent COVID-19 vaccine was administered at a hospital. The patient was not pregnant at the time of vaccination. Medical history included asthma and hypothyroidism. The patient had no known allergies. Concomitant medications included unspecified medications. It was reported that the patient received other medications within 2 weeks of vaccination. The patient previously received the first dose of bnt162b2 (BNT162B2, lot number: EK5730, expiry date: not reported), via an unspecified route of administration, on 16Dec2020 11:00 AM at a single dose on the right arm for COVID-19 immunization. She did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 14Jan2021 04:30 AM, the patient experienced "Foul taste, everything tastes like it was slathered in old butter, nothing tastes right." The patient was not diagnosed with COVID-19 prior to vaccination and has not been tested for COVID-19 post vaccination. The patient did not receive any treatment for the reported adverse event. Outcome of the event was not recovered.

Other Meds:

Current Illness:

ID: 0973569
Sex: F
Age:
State: IL

Vax Date: 01/11/2021
Onset Date: 01/11/2021
Rec V Date: 01/26/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Allergic reaction; Red, blotchy rash on face and chest; Red, blotchy rash on face and chest; This is a spontaneous report from a contactable health professional reported for herself. A 42-year-old non-pregnant female patient received second dose of BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine; lot number: EL1283), via an unspecified route of administration in the right arm on 11Jan2021 at a single dose for COVID-19 immunization. The patient was vaccinated in a hospital facility. Medical history included type 2 diabetes, hypothyroidism, and multiple food and med allergies. Prior to vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The patient is taking unspecified concomitant medication/s (received within 2 weeks of vaccination). The patient previously received first dose of BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine; lot number: EL1283) in the right arm on 21Dec2020 05:00 PM at a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 11Jan2021 12:45 PM, the patient experienced allergic reaction of red, blotchy rash on face and chest. The adverse events resulted in emergency room/department or urgent care and doctor or other healthcare professional office/clinic visit. The patient received Benadryl/prednisone as treatments. The outcome of the events was recovering. The events were considered non-serious.

Other Meds:

Current Illness:

ID: 0973570
Sex: M
Age:
State:

Vax Date: 01/14/2021
Onset Date: 01/14/2021
Rec V Date: 01/26/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: headache; chills; fever; muscle soreness; injection site soreness; This is a spontaneous report from a non-contactable consumer (wife). A 78-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration on 14Jan2021 at single dose for COVID-19 immunization. Medical history and concomitant medications were not reported. On 14Jan2021 19:00, the patient had headache, chills, fever, muscle soreness and injection site soreness. Outcome was unknown. Information on batch number has been requested.

Other Meds:

Current Illness:

ID: 0973571
Sex: F
Age:
State: MD

Vax Date: 01/14/2021
Onset Date: 01/15/2021
Rec V Date: 01/26/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Diarrhea; This is a spontaneous report from a contactable health professional (reported for herself). A 57-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: unknown), via an unspecified route of administration on 14Jan2021 (07:30 AM) at single dose for Covid-19 immunization. The patient's medical history included psoriatic arthritis, seizure disorder, and allergy to latex. Concomitant medication included esomeprazole sodium (NEXIUM). The patient was not diagnosed with COVID-19 prior to vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient experienced diarrhea on 15Jan2021 (06:00 AM). There was no treatment received for the adverse event. The outcome of event was not recovered. The patient has not been tested for COVID-19 since the vaccination. This case is non-serious. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds: Nexium [Esomeprazole Sodium]

Current Illness:

ID: 0973572
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 01/26/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: experience funny taste in her mouth (somewhat metallic like); This is a spontaneous report received from a non-contactable other healthcare professional. A 62-year-old female patient received the first dose of BNT162B2 (BNT162B2 PFIZER-BIONTECH COVID-19 VACCINE, lot number: EK9231, expiry date: unknown), via an unspecified route of administration, on an unspecified date, at single dose, for COVID-19 immunization. Medical history included ongoing disability and gait disturbance (difficulty ambulating long distances due to being disabled). The patient's concomitant medications were not reported. During the patient's 15-minute waiting period after the vaccination, the patient began to experience funny taste in her mouth (somewhat metallic like). Treatment included antihistamines (unspecified). The response to treatment was good. The patient was doing well upon discharge/leaving. She was escorted out via wheelchair only due difficulty ambulating long distances due to being disabled but is otherwise at baseline. The outcome of the event was recovering (reported as "reports some improvement in change in taste prior to discharge/leaving"). The reporter assessed this case as non-serious. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness: Difficulty in walking; Disability

ID: 0973573
Sex: M
Age:
State: MT

Vax Date: 01/14/2021
Onset Date: 01/14/2021
Rec V Date: 01/26/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Sore arm at site of injection; This is a spontaneous report from a contactable healthcare professional. A 48-year-old male patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number EL3246), intramuscular (left arm) from 14Jan2021 15:00 to 14Jan2021 15:00 at a single dose for covid-19 immunization. Medical history included High Blood Pressure. Concomitant medication included losartan. The patient experienced sore arm at site of injection on 14Jan2021 21:00. No treatment was received for the event. The outcome of the event was not recovered.

Other Meds: Losartan

Current Illness:

ID: 0973574
Sex: U
Age:
State: OH

Vax Date:
Onset Date:
Rec V Date: 01/26/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: after vaccination with fever; headache; body aches; This is a spontaneous report from a contactable nurse. This nurse reported similar events for 6 patients. This is 1st of 6th reports. A patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date at single dose for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. The patient experienced fever, headache and body aches on an unspecified date. Event took place after use of product. The outcome of events was unknown. Information about lot/batch number has been requested.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021034234 Same reporter/drug/event/different patient;US-PFIZER INC-2021034230 Same reporter/drug/event/different patient;US-PFIZER INC-2021034231 Same reporter/drug/event/different patient;US-PFIZER INC-2021034232 Same reporter/drug/event/different patient;US-PFIZER INC-2021034233 Same reporter/drug/event/different patient

Other Meds:

Current Illness:

ID: 0973575
Sex: U
Age:
State: OH

Vax Date:
Onset Date:
Rec V Date: 01/26/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: after vaccination with fever; headache; body aches; This is a spontaneous report from contactable nurse. This nurse reported similar events for 6 patients. This is 2nd of 6 reports. A patient of an unknown age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date at single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. The patient experienced fever, headache and body aches on an unspecified date. Event took place after use of product. It was reported that "6 staff call in the day after vaccination with fever, headache and body aches". The outcome of events was unknown. Information about lot/batch number has been requested.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021034195 Same reporter/drug/event/different patient.

Other Meds:

Current Illness:

ID: 0973576
Sex: U
Age:
State: OH

Vax Date:
Onset Date:
Rec V Date: 01/26/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: after vaccination with fever; headache; body aches; This is a spontaneous report from contactable nurse. This nurse reported similar events for 6 patients. This is 3rd of 6 reports. A patient of an unknown age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date at single dose for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. The patient experienced fever, headache and body aches on an unspecified date. Event took place after use of product. It was reported that "6 staff call in the day after vaccination with fever, headache and body aches". The outcome of events was unknown. Information about lot/batch number has been requested.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021034195 Same reporter/drug/event/different patient

Other Meds:

Current Illness:

ID: 0973577
Sex: U
Age:
State: OH

Vax Date:
Onset Date:
Rec V Date: 01/26/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: after vaccination with fever; headache; body aches; This is a spontaneous report from a contactable nurse. This nurse reported similar events for 6 patients. This is 4th of 6th reports. A patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date at single dose for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. The patient experienced fever, headache and body aches on an unspecified date. Event took place after use of product. The outcome of events was unknown. Information about lot/batch number has been requested.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021034195 Same reporter/drug/event/different patient

Other Meds:

Current Illness:

ID: 0973578
Sex: U
Age:
State: OH

Vax Date:
Onset Date:
Rec V Date: 01/26/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: fever; headache; body aches; This is a spontaneous report from a contactable Nurse via sales representative. This Nurse reported similar events for 6 patients. This is 5th of 6 reports. A patient of unspecified age and gender received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) , via an unspecified route of administration on an unspecified date at single dose for covid-19 immunisation . The patient medical history was not reported. The patient's concomitant medications were not reported. The patient experienced fever, headache, body aches on an unspecified date. The outcome of events was unknown. information on the LOT/Batch number has been requested; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021034195 Same reporter/drug/event/different patient

Other Meds:

Current Illness:

ID: 0973579
Sex: U
Age:
State: OH

Vax Date:
Onset Date:
Rec V Date: 01/26/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: fever; headache; body aches; This is a spontaneous report from a contactable nurse. This nurse reported similar events for 6 patients. This is 6th of six reports. A patient of unspecified age and gender received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration on an unspecified date at single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient experienced fever, headache, body aches on an unspecified date. The outcome of events was unknown. information on the Lot/Batch number has been requested.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021034195 Same reporter/drug/event/different patient

Other Meds:

Current Illness:

ID: 0973580
Sex: F
Age:
State: MI

Vax Date: 01/09/2021
Onset Date: 01/09/2021
Rec V Date: 01/26/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: At vaccine site, had numbness; tingling on lips and tongue on left side of face; tingling on left side of face; headache/Mild headache; dizzy; exhausted; GI - mild naseau; intestinal discomfort; This is a spontaneous report from a contactable consumer. A 72-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; lot number: EL32216), via an unspecified route of administration on 09Jan2021 10:00 at SINGLE DOSE at arm left for covid-19 immunisation. Medical history included known allergies: yes. Concomitant medications included levothyroxine sodium (SYNTHYROID), lisinopril, fexofenadine hydrochloride (ALLEGRA), progesterone (PROMETRIUM [PROGESTERONE]), and "PULMICO". On 09Jan2021, it was reported that At vaccine site, had numbness, tingling on lips and tongue on left side of face. This has not subsided, sometimes spreading, waxing & waning. Same day - headache, dizzy, exhausted - two days. GI - mild naseau (nausea), intestinal discomfort - on going. Mild headache continuing. The patient did not receive treatment for the events. The outcome of the events was reported as recovering.

Other Meds: Synthroid; Lisinopril; Allegra; Prometrium [Progesterone]; Pulmicort

Current Illness:

Total 2021 VAERS Injuries: 599,999

Page last modified: 03 October 2021 5:28pm